175 related articles for article (PubMed ID: 20933445)
21. The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma.
Miyazaki Y; Kosaka T; Mikami S; Kikuchi E; Tanaka N; Maeda T; Ishida M; Miyajima A; Nakagawa K; Okada Y; Sato Y; Oya M
Clin Cancer Res; 2012 Aug; 18(15):4145-53. PubMed ID: 22675166
[TBL] [Abstract][Full Text] [Related]
22. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.
Walton TJ; Novara G; Matsumoto K; Kassouf W; Fritsche HM; Artibani W; Bastian PJ; Martínez-Salamanca JI; Seitz C; Thomas SA; Ficarra V; Burger M; Tritschler S; Karakiewicz PI; Shariat SF
BJU Int; 2011 Aug; 108(3):406-12. PubMed ID: 21078048
[TBL] [Abstract][Full Text] [Related]
23. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
24. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
[TBL] [Abstract][Full Text] [Related]
25. Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
Fernández MI; Shariat SF; Margulis V; Bolenz C; Montorsi F; Suardi N; Remzi M; Wood CG; Roscigno M; Kikuchi E; Oya M; Zigeuner R; Langner C; Weizer A; Lotan Y; Koppie TM; Raman JD; Karakiewicz P; Bensalah K; Schultz M; Bernier P
Urology; 2009 Jan; 73(1):142-6. PubMed ID: 18845322
[TBL] [Abstract][Full Text] [Related]
26. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Kabbani W; Langner C; Guo CC; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
BJU Int; 2011 Oct; 108(8):1286-91. PubMed ID: 21332905
[TBL] [Abstract][Full Text] [Related]
27. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
[TBL] [Abstract][Full Text] [Related]
28. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.
Burger M; Shariat SF; Fritsche HM; Martinez-Salamanca JI; Matsumoto K; Chromecki TF; Ficarra V; Kassouf W; Seitz C; Pycha A; Tritschler S; Walton TJ; Novara G
World J Urol; 2011 Aug; 29(4):465-72. PubMed ID: 21630120
[TBL] [Abstract][Full Text] [Related]
29. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
Gurbuz C; Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
J Endourol; 2011 May; 25(5):775-9. PubMed ID: 21388245
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years.
Berger A; Haber GP; Kamoi K; Aron M; Desai MM; Kaouk JH; Gill IS
J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229
[TBL] [Abstract][Full Text] [Related]
31. Factors impacting survival in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy.
Mouracade P; Velten M; Gigante M; Alenda O; Ploussard G; Obadia F; Timsit MO; Mejean A
Can J Urol; 2012 Feb; 19(1):6105-10. PubMed ID: 22316512
[TBL] [Abstract][Full Text] [Related]
32. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
Roscigno M; Cha EK; Rink M; Seitz C; Novara G; Chromecki TF; Fritsche HM; Matsumoto K; Walton TJ; Carballido J; Filippo Da Pozzo L; Bertini R; Ficarra V; Otto W; Karakiewicz PI; Pycha A; Fajkovic H; Naspro R; Scherr DS; Montorsi F; Shariat SF
BJU Int; 2012 Sep; 110(5):674-81. PubMed ID: 22348322
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
Fajkovic H; Cha EK; Jeldres C; Donner G; Chromecki TF; Margulis V; Novara G; Lotan Y; Raman JD; Kassouf W; Seitz C; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Breinl E; Pycha A; Ficarra V; Montorsi F; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Mar; 187(3):845-51. PubMed ID: 22248522
[TBL] [Abstract][Full Text] [Related]
34. Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma.
Bolenz C; Fernández MI; Trojan L; Herrmann E; Becker A; Weiss C; Alken P; Ströbel P; Michel MS
Urology; 2008 Aug; 72(2):364-9. PubMed ID: 18579189
[TBL] [Abstract][Full Text] [Related]
35. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
Capitanio U; Shariat SF; Isbarn H; Weizer A; Remzi M; Roscigno M; Kikuchi E; Raman JD; Bolenz C; Bensalah K; Koppie TM; Kassouf W; Fernández MI; Ströbel P; Wheat J; Zigeuner R; Langner C; Waldert M; Oya M; Guo CC; Ng C; Montorsi F; Wood CG; Margulis V; Karakiewicz PI
Eur Urol; 2009 Jul; 56(1):1-9. PubMed ID: 19361911
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
Kuroda K; Asakuma J; Horiguchi A; Tasaki S; Yoshii H; Sato A; Ito K; Seguchi K; Sumitomo M; Asano T
Urol Int; 2012; 88(2):225-31. PubMed ID: 22236640
[TBL] [Abstract][Full Text] [Related]
37. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
Wheat JC; Weizer AZ; Wolf JS; Lotan Y; Remzi M; Margulis V; Wood CG; Montorsi F; Roscigno M; Kikuchi E; Zigeuner R; Langner C; Bolenz C; Koppie TM; Raman JD; Fernández M; Karakiewizc P; Capitanio U; Bensalah K; Patard JJ; Shariat SF
Urol Oncol; 2012; 30(3):252-8. PubMed ID: 20451416
[TBL] [Abstract][Full Text] [Related]
38. Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma.
Dragicevic D; Djokic M; Pekmezovic T; Vuksanovic A; Micic S; Hadzi-Djokic J; Tulic C; Milenkovic D; Pljesa-Ercegovac M; Simic T
Urol Int; 2009; 82(3):335-40. PubMed ID: 19440024
[TBL] [Abstract][Full Text] [Related]
39. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.
Bolenz C; Fernández MI; Trojan L; Hoffmann K; Herrmann E; Steidler A; Weiss C; Ströbel P; Alken P; Michel MS
BJU Int; 2009 Apr; 103(8):1040-6. PubMed ID: 18990139
[TBL] [Abstract][Full Text] [Related]
40. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience.
Mason RJ; Kassouf W; Bell DG; Lacombe L; Kapoor A; Jacobsen N; Fairey A; Izawa J; Black P; Tanguay S; Chin J; So A; Lattouf JB; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Fradet Y; Rendon RA
Urology; 2012 Apr; 79(4):840-5. PubMed ID: 22365453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
